Treatment Options for Low DHEA Levels
DHEA replacement therapy is recommended for patients with adrenal insufficiency who have persistent symptoms despite adequate primary replacement therapy, with a typical starting dose of 25-50 mg orally once daily in the morning. 1
Diagnostic Considerations Before Treatment
Before initiating DHEA treatment, it's important to understand the context of low DHEA levels:
Determine if low DHEA is part of primary or secondary adrenal insufficiency
- Primary: High ACTH, low cortisol, electrolyte abnormalities (↓Na, ↑K)
- Secondary: Low ACTH, low cortisol, usually normal electrolytes 1
Confirm diagnosis with appropriate testing:
- Morning serum cortisol and ACTH levels
- Cosyntropin stimulation test (gold standard)
- DHEA/DHEAS blood levels 1
Treatment Algorithm for Low DHEA
For patients with diagnosed adrenal insufficiency:
For patients with age-related DHEA decline:
Clinical Indications for DHEA Replacement
DHEA replacement may be beneficial for patients with:
- Persistent symptoms despite adequate primary adrenal replacement therapy 1, 2
- Symptoms that may benefit from DHEA supplementation:
Monitoring and Follow-up
- Regular assessment of clinical response and symptoms
- Annual follow-up including:
- Overall well-being assessment
- Weight and blood pressure measurement
- Serum electrolyte testing
- Screening for other autoimmune disorders 1
Potential Benefits of DHEA Replacement
Research suggests DHEA supplementation may provide:
- Improved quality of life and psychological well-being 2, 3
- Enhanced body composition and muscle strength 3
- Improved bone mineral density 2, 3
- Beneficial effects on metabolic markers 2
- Immunomodulatory effects 3
Important Caveats and Limitations
- DHEA is not considered essential for life, unlike glucocorticoid and mineralocorticoid replacement 2
- Research results are inconsistent across studies 2
- In the US, DHEA is classified as a dietary supplement, not a medication 5
- In many European countries, DHEA is considered a hormone but not approved for routine use 5
- Long-term safety data is limited 3
Special Considerations
- DHEA replacement is particularly relevant for women with adrenal insufficiency who may experience more pronounced benefits 3, 5
- For patients with immune-related adverse events from immune checkpoint inhibitor therapy, DHEA replacement may be considered as part of the management strategy 6
- The age-related decline of DHEA (approximately 2% per year after adulthood) is a normal physiological process, not necessarily requiring intervention in all cases 7, 8